Ligand id: 9041

Name: brivaracetam

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 63.4
Molecular weight 212.15
XLogP 0.8
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

No information available.
Summary of Clinical Use
Brivaracetam was EMA and FDA approved in 2016 as an adjunctive therapeutic for the treatment of partial-onset seizures in patients with epilepsy. Use in pediatric patients age four years and older was FDA approved in May 2018.
External links